IPO registrations (S-1, F-1) · Registrants
Sight Sciences, Inc.
- SEC CIK
- 1531177 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-06-23, last 2021-07-14; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-07-15; declared effective 2021-07-14
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, Menlo Park, CA 94025
- EIN
- 80-0625749
- Ticker
- SGHT (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Sight Sciences, Inc. on the corporate pages
Offering terms
- Proposed price range
- $23.00–$24.00 per share (S-1/A filed 2021-07-14)
- Final price
- $24.00 per share, within the range (424B4 filed 2021-07-15, an initial public offering)
- Shares sold
- 10,000,000
- Gross proceeds
- $240,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SGHT
- Lead underwriters
- Morgan Stanley (3,650,000 shares); BofA Securities (3,650,000 shares); Citigroup (1,350,000 shares); Piper Sandler (1,350,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SIGHT SCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Sight Sciences, Inc. Fuzzy (name and state)
- Business registration: Sight Sciences, Inc. Fuzzy (name and state)
- Business registration: Sight Sciences, Inc. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, Inc. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Business registration: SIGHT SCIENCES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: SIGHT SCIENCES, INC. EXACT (EIN (EXACT))
- Form D issuer: Sight Sciences, Inc. EXACT (CIK (EXACT))
- Lobbying client: SIGHT SCIENCES Fuzzy (name and state)
- Lobbying client: SIGHT SCIENCES Fuzzy (name and state)
- Lobbying client: SIGHT SCIENCES Fuzzy (name and state)
- Lobbying client: SIGHT SCIENCES Fuzzy (name and state)
- Lobbying client: SIGHT SCIENCES Fuzzy (name and state)
- Lobbying client: SIGHT SCIENCES, INC. Fuzzy (name and state)
- SEC filer: Sight Sciences, Inc. EXACT (CIK (EXACT))
- Person page: Mack H Hicks Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-06-23 | S-1 | S-1 (registration) | Sight Sciences, Inc. | 0001193125-21-197314 ↗ |
| 2021-07-08 | S-1/A | S-1/A (amendment) | Sight Sciences, Inc. | 0001193125-21-210231 ↗ |
| 2021-07-14 | S-1/A | S-1/A (amendment) | Sight Sciences, Inc. | 0001193125-21-214542 ↗ |
| 2021-07-14 | EFFECT | EFFECT (declared effective) | Sight Sciences, Inc. | 9999999995-21-002761 ↗ |
| 2021-07-15 | 424B4 | 424B4 (final prospectus) | Sight Sciences, Inc. | 0001193125-21-216560 ↗ |
| 2023-05-24 | EFFECT | EFFECT (declared effective) | Sight Sciences, Inc. | 9999999995-23-001514 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-14 | S-1/A | registration statement | $23.00–$24.00 | 10,000,000 | - | Nasdaq SGHT | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2021-07-15 | 424B4 | final prospectus | $24.00 | 10,000,000 | $240,000,000 | Nasdaq SGHT | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Badawi David | Director,Officer | Chief Technology Officer | 28 | 2021–2026 | |
| Badawi Paul | Director,Officer; Director,Officer,TenPercentOwner | President and CEO | 23 | 2021–2026 | |
| D1 Capital Partners L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Encrantz Staffan | Director; Director,TenPercentOwner | 22 | 2021–2026 | ||
| HAYDEN JEREMY B. | Officer | Chief Legal Officer | 24 | 2021–2026 | |
| HEP Partners LLC | TenPercentOwner | 3 | 2021–2022 | ||
| HH-IOP Partners, L.P. | TenPercentOwner | 3 | 2021–2022 | ||
| HH Sight LLC | TenPercentOwner | 3 | 2021–2022 | ||
| HH Sight Partners GP, L.P. | TenPercentOwner | 3 | 2021–2022 | ||
| HH Sight Partners, L.P. | TenPercentOwner | 3 | 2021–2022 | ||
| Hicks Mack H. | Director,TenPercentOwner | 4 | 2021–2022 | person page Fuzzy | |
| HICKS THOMAS O | TenPercentOwner | 3 | 2021–2022 | ||
| KCK LTD. | TenPercentOwner | 2 | 2021 | ||
| Offer Andrew | Director | 2 | 2021 | ||
| O'Neil Shawn | Officer | Chief Commercial Officer | 2 | 2021–2022 | |
| Park Sam Boong | Officer | Chief Operating Officer | 11 | 2021–2024 | |
| Rogers Erica J. | Director | 5 | 2021–2025 | ||
| Schroeder Valeska | Director | 3 | 2021–2023 | ||
| Selnick Jesse | Officer | Chief Financial Officer | 7 | 2021–2023 | |
| Sundheim Daniel S. | TenPercentOwner | 3 | 2021–2023 | ||
| Zurbay Donald | Director | 6 | 2021–2026 | ||
| Larsen-Becker Brenda Jane | Director | 5 | 2022–2025 | ||
| Fountain Tamara | Director | 6 | 2022–2026 | ||
| Rodberg James | Officer | Chief Financial Officer; See Remarks | 10 | 2023–2026 | |
| Bauerlein Alison | Officer | Chief Financial Officer; Chief Operating Officer; See remarks; See Remarks | 19 | 2023–2026 | |
| Mazzacco Catherine | Director | 6 | 2023–2026 | ||
| Link Matthew | Officer | Chief Commercial Officer | 9 | 2023–2025 | |
| Raheja Manohar K. | Officer | EVP, Research & Development | 9 | 2024–2025 | |
| Taylor Brenton | Officer | EVP, Operations; EVP, Operations & R&D | 9 | 2024–2026 | |
| Burbach Gerhard F | Director | 3 | 2025–2026 | ||
| Rashid Kashif | Officer | Chief Legal Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-12-10 | Sight Sciences, Inc. | Biotechnology | $23,249,972 | $23,249,972 | 4 | 1 |
| 2020-04-14 | Sight Sciences, Inc. | Biotechnology | $30,500,000 | $30,150,002 | 4 | 2 |
| 2019-08-26 | Sight Sciences, Inc. | Biotechnology | $31,502,481 | $30,749,980 | 2 | 2 |
| 2017-07-20 | Sight Sciences, Inc. | Biotechnology | $22,226,216 | $19,726,217 | 25 | 2 |
| 2015-10-30 | Sight Sciences, Inc. | Biotechnology | $7,000,000 | $6,939,969 | 17 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.